Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06383572
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2024-04-22
Brief Title:
Phase III Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of RelapseRefractory Myeloid Malignancies
Sponsor:
Organization:
MD Anderson Cancer Center